Help | Scores |Exit
Fragmin | Magnex | Solu Medrol
Celiprolol Drug Name:  
A|B|C|D|E|F|G|H|I|K|L|M|N|O|P|Q|R|S|T|V|Z
Indications
Dosages
Interactions
Precautions
Contraindications
Adverse Reactions
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interactions:

Acarbose

  • Adverse Effect: hypoglycemia, hyperglycemia, or hypertension  
  • Clinical Management: If the use of a beta blocker is required in a diabetic, watch for decreased diabetic control by monitoring the patients glucose carefully. Cardioselective beta blockers (Atenolol, Metoprolol) cause less disturbance of glucose metabolism and less masking of hypoglycemic effects. Propranolol accounts for the majority of positive reports of an interaction and should clearly be avoided.

    Adrenaline

  • Adverse Effect: Hypertension, bradycardia, resistance to Adrenaline in anaphylaxis  
  • Clinical Management: Concurrent use should be avoided if possible. However, if used concurrently, monitor blood pressure carefully. If a nonselective Celiprolol causes resistance to Adrenaline in anaphylactic shock, glucagon may be effective in a dose of 1 mg or more intravenously every five minutes.

    Amiodarone

  • Adverse Effect: hypotension, bradycardia, or cardiac arrest  
  • Clinical Management: Monitor cardiac function carefully. Amiodarone should be used with caution in patients receiving beta blockers particularly if there is suspicion of underlying dysfunction of the sinus node, such as bradycardia or sick sinus syndrome, or if there is partial AV block.

    Amlodipine

  • Adverse Effect: hypotension and/or bradycardia  
  • Clinical Management: If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure.

    Benidipine

  • Adverse Effect: hypotension and/or bradycardia  
  • Clinical Management: If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure.

    Celecoxib

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Chlorpropamide

  • Adverse Effect: Hypoglycemia, hyperglycemia, or hypertension  
  • Clinical Management: If the use of a beta blocker is required in a diabetic, watch for decreased diabetic control by monitoring the patients glucose carefully. Cardioselective beta blockers (atenolol, metoprolol) cause less disturbance of glucose metabolism and less masking of hypoglycemic effects. Propranolol accounts for the majority of positive reports of an interaction and should clearly be avoided.

    Clonidine

  • Adverse Effect: exaggerated clonidine withdrawal response (acute hypertension)  
  • Clinical Management: When clonidine is to be withdrawn from concomitant therapy with a beta blocker, discontinue the beta blocker first, and monitor blood pressure carefully. Labetalol (alph/beta blocker) or alpha blockers (eg, prazosin, doxazosin) may prevent rebound hypertension.

    Diclofenac Preps.

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Digoxin

  • Adverse Effect: AV block and possible digoxin toxicity  
  • Clinical Management: When beta blockers and digoxin are to be given concomitantly, carefully monitor ECG and digoxin serum concentrations. Adjust doses accordingly.

    Diltiazem

  • Adverse Effect: hypotension, bradycardia, AV conduction disturbances
  • Clinical Management: If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure. A dosage adjustment for hepatically metabolized beta blockers may be required.

    Doxazosin

  • Adverse Effect: an exaggerated hypotensive response to the first dose of the alpha blocker  
  • Clinical Management: When concurrent therapy with an alpha blocker and a beta blocker is required, initiate the alpha blocker with a smaller than usual dose, preferably at bedtime. Monitor the patient closely for hypotension.

    Felodipine

  • Adverse Effect: hypotension and/or bradycardia  
  • Clinical Management: If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure.

    Flunarizine

  • Adverse Effect: hypotension, bradycardia, and AV conduction disturbances  
  • Clinical Management: If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure or bradyarrhythmias.

    Flurbiprofen

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Glibenclamide

  • Adverse Effect: hypoglycemia, hyperglycemia, or hypertension  
  • Clinical Management: If the use of a beta blocker is required in a diabetic, watch for decreased diabetic control by monitoring the patients glucose carefully. Cardioselective beta blockers (atenolol, metoprolol) cause less disturbance of glucose metabolism and less masking of hypoglycemic effects.Propranolol accounts for the majority of positive reports of an interaction and should clearly be avoided.

    Gliclazide

  • Adverse Effect: hypoglycemia, hyperglycemia, or hypertension  
  • Clinical Management: If the use of a beta blocker is required in a diabetic, watch for decreased diabetic control by monitoring the patients glucose carefully. Cardioselective beta blockers (atenolol, metoprolol) cause less disturbance of glucose metabolism and less masking of hypoglycemic effects. Propranolol accounts for the majority of positive reports of an interaction and should clearly be avoided.

    Glimepiride

  • Adverse Effect: hypoglycemia, hyperglycemia, or hypertension  
  • Clinical Management: If the use of a beta blocker is required in a diabetic, watch for decreased diabetic control by monitoring the patients glucose carefully. Cardioselective beta blockers (atenolol, metoprolol) cause less disturbance of glucose metabolism and less masking of hypoglycemic effects. Propranolol accounts for the majority of positive reports of an interaction and should clearly be avoided.

    Glipizide

  • Adverse Effect: hypoglycemia, hyperglycemia, or hypertension  
  • Clinical Management: If the use of a beta blocker is required in a diabetic, watch for decreased diabetic control by monitoring the patients glucose carefully. Cardioselective beta blockers (atenolol, metoprolol) cause less disturbance of glucose metabolism and less masking of hypoglycemic effects. Propranolol accounts for the majority of positive reports of an interaction and should clearly be avoided.

    Guar Gum

  • Adverse Effect: hypoglycemia, hyperglycemia, or hypertension  
  • Clinical Management: If the use of a beta blocker is required in a diabetic, watch for decreased diabetic control by monitoring the patients glucose carefully. Cardioselective beta blockers (atenolol, metoprolol) cause less disturbance of glucose metabolism and less masking of hypoglycemic effects. Propranolol accounts for the majority of positive reports of an interaction and should clearly be avoided.

    Ibuprofen

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Indomethacin

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Insulin Lispro

  • Adverse Effect: hypoglycemia, hyperglycemia, or hypertension  
  • Clinical Management: If the use of a beta blocker is required in a diabetic, watch for decreased diabetic control by monitoring the patients glucose carefully. Cardioselective beta blockers (atenolol, metoprolol) cause less disturbance of glucose metabolism and less masking of hypoglycemic effects. Propranolol accounts for the majority of positive reports of an interaction and should clearly be avoided.

    Ketoprofen

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Ketorolac

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Lacidipine

  • Adverse Effect: hypotension and/or bradycardia  
  • Clinical Management: If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure.

    Lidoflazine

  • Adverse Effect: hypotension, bradycardia, and AV conduction disturbances  
  • Clinical Management: If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure or bradyarrhythmias.

    Mefenamic Acid

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Meloxicam

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Metformin

  • Adverse Effect: hypoglycemia, hyperglycemia, or hypertension   .
  • Clinical Management: If the use of a beta blocker is required in a diabetic, watch for decreased diabetic control by monitoring the patients glucose carefully. Cardioselective beta blockers (atenolol, metoprolol) cause less disturbance of glucose metabolism and less masking of hypoglycemic effects. Propranolol accounts for the majority of positive reports of an interaction and should clearly be avoided.

    Methyldopa

  • Adverse Effect: exaggerated hypertensive response, tachycardia, or arrhythmias during physiologic stress or exposure to exogenous catecholamines  
  • Clinical Management: Monitor blood pressure carefully during concurrent therapy, especially during excessive physiologic stress or use of exogenous catecholamines such as phenylpropanolamine.

    Nabumetone

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Naproxen

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Nifedipine

  • Adverse Effect: hypotension and/or bradycardia  
  • Clinical Management: If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure.

    Nimesulide

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Nimodipine

  • Adverse Effect: hypotension and/or bradycardia  
  • Clinical Management: If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure.

    Nitrendipine

  • Adverse Effect: hypotension and/or bradycardia  
  • Clinical Management: If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure.

    Oxyphenbutazone

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Paracetamol

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Phenacetin

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Phenylbutazone

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Piroxicam

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Prazosin

  • Adverse Effect: an exaggerated hypotensive response to the first dose of the alpha blocker  
  • Clinical Management: When concurrent therapy with an alpha blocker and a beta blocker is required, initiate the alpha blocker with a smaller than usual dose, preferably at bedtime. Monitor the patient closely for hypotension.

    Prazosin - BPH

  • Adverse Effect: An exaggerated hypotensive response to the first dose of the alpha blocker  
  • Clinical Management: When concurrent therapy with an alpha blocker and a beta blocker is required, initiate the alpha blocker with a smaller than usual dose, preferably at bedtime. Monitor the patient closely for hypotension.

    Procainamide

  • Adverse Effect: an increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest)  
  • Clinical Management: The concurrent administration of Procainamide is not recommended. The Procainamide should be withheld for at least three half-lives prior to dosing.

    Ritodrine

  • Adverse Effect: potential interference with tocolytic action of ritodrine  
  • Clinical Management: It is possible to successfully treat a patient with both a beta blocker and a beta mimetic if an appropriate dosage is found and the clinical response is monitored.

    Tenoxicam

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Terazosin

  • Adverse Effect: an exaggerated hypotensive response to the first dose of the alpha blocker  
  • Clinical Management: When concurrent therapy with an alpha blocker and a beta blocker is required, initiate the alpha blocker with a smaller than usual dose, preferably at bedtime. Monitor the patient closely for hypotension.

    Terazosin - BPH

  • Adverse Effect: An exaggerated hypotensive response to the first dose of the alpha blocker  
  • Clinical Management: When concurrent therapy with an alpha blocker and a beta blocker is required, initiate the alpha blocker with a smaller than usual dose, preferably at bedtime. Monitor the patient closely for hypotension.

    Tolbutamide

  • Adverse Effect: hypoglycemia, hyperglycemia, or hypertension  
  • Clinical Management: If the use of a beta blocker is required in a diabetic, watch for decreased diabetic control by monitoring the patients glucose carefully. Cardioselective beta blockers (atenolol, metoprolol) cause less disturbance of glucose metabolism and less masking of hypoglycemic effects. Propranolol accounts for the majority of positive reports of an interaction and should clearly be avoided.

    Verapamil

  • Adverse Effect: hypotension, bradycardia  
  • Clinical Management: If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure.
  • Calcium Salts
    Captopril
    Carbamazepine
    CastorOil
    Cefaclor
    Cefadroxil
    CefazolinSodium
    Cefdinir
    CefepimeHydrochloride
    Cefixime
    CefotaximeSodium
    CeftriaxoneSodium
    CefuroximeAxetil
    Cephalexin Hydrochloride Monohydrate
    CetirizineHydrochloride
    Chloral Hydrate
    Chloramphenicol
    Chlordiazepoxide
    Chloroquine Hydrochloride
    Chlorpheniramine Maleate
    Chlorpromazine Hydrochloride
    Chlorthalidone
    Cholestyramine
    Cimetidine
    Ciprofloxacin
    Ciprofloxacin Hydrochloride
    Cisplatin
    Clarithromycin
    ChemastineFumarate
    Clindamycin Hydrochloride
    Clonazepam
    Clotrimazole
    CloxacillinSodium
    CodeinePhosphate
    CortisoneAcetate
    Co-trimoxazole
    CromolynSodium
    Cyanocobalamin
    Cycloserine
    Cyclosporine
    Chlormezanone
    Chlorpropamide
    Clostebol
    Clotrimazole - Topical
    Clotrimazole - VU
    Clozapine
    Coal Tar
    Colchicine
    Colistin Sulphate
    Colloidal Bismuth
    Conj Estrogen
    Corticotrophin
    Cotrimoxazole
    Crotamiton
    Cyclandelate
    Cyclopentolate
    Cyclophosphamide
    Cyproheptadine
    Cytarabine
    Calcipotriol
    Calcitonin
    Calcium Dobesilate
    Candesartan
    Capreomycin
    Carbenicillin
    Carbidopa
    Carbimazole
    Carboplatin
    Carboprost
    Cardioplegia
    Carisoprodol
    Carvedilol
    Catalin
    Cefoperazone
    Cefpirome
    Cefpodoxime
    Ceftazidime
    Ceftibuten
    Ceftizoxime
    Cefuroxime
    Celecoxib
    Celiprolol
    Centchroman
    Cephaloridine
    Cetrimide
    Chenodeoxycholic acid
    Chlorambucil
    Chlorhexidine Gluconate
    Chloroxylenol
    Chlorzoxazone
    Cholera Vaccine
    Ciclopiroxolamine
    Ciclopiroxolamine - VU
    Cinnarizine
    Cisapride
    Citalopram
    Clemastine
    Clidinium Br
    Clidinium Br - Antispas
    Clobazam
    Clobetasol
    Clofazimine
    Clomiphene
    Clomipramine
    Clonidine
    Clopamide
    Clopidogrel
     
    Disclaimer